← Holders
BML Capital Management, LLC
What BML Capital Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1616824 · Filed Nov 6, 2026
- Positions
- 20
- Reported value
- $187.6M
- Opened
- 4
- Closed
- 2
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$109.2M20 positions
- Dec 31, 2025$115.7M16 positions
- Mar 31, 2026$155.8M16 positions
- Jun 30, 2026$176.1M18 positions
- Sep 30, 2026$187.6M20 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
ACRSAclaris Therapeutics, Inc. | 11M | −8.5% | $57.6M | 30.7% |
AVIRAtea Pharmaceuticals, Inc. | 6.8M | −2.9% | $35.2M | 18.8% |
ENGNenGene Therapeutics Inc. | 6.7M | New | $13.3M | 7.1% |
PMVPPMV Pharmaceuticals, Inc. | 7.3M | +37.5% | $12.2M | 6.5% |
KHCKraft Heinz Co | 475K | +2.2% | $10.8M | 5.8% |
TLYSTilly's, Inc. | 2.2M | ±0% | $10M | 5.3% |
KMXCarMax Inc | 172.5K | ±0% | $9.5M | 5.1% |
OMOutset Medical, Inc. | 2.5M | ±0% | $7.6M | 4% |
TGTTarget Corp | 37.5K | ±0% | $5.9M | 3.1% |
SEERSeer, Inc. | 2.2M | New | $4.9M | 2.6% |
TILInstil Bio, Inc. | 645.6K | ±0% | $4.7M | 2.5% |
CNTBConnect Biopharma Holdings Ltd | 3.9M | +574.1% | $4.3M | 2.3% |
ORMPOramed Pharmaceuticals Inc. | 884.4K | +2.1% | $4.1M | 2.2% |
JANXJanux Therapeutics, Inc. | 151.1K | −2.5% | $2.6M | 1.4% |
PLRXPliant Therapeutics, Inc. | 1.5M | ±0% | $1.7M | 0.9% |
LENZLENZ Therapeutics, Inc. | 283.1K | New | $1.1M | 0.6% |
IMAImageneBio, Inc. | 200.7K | ±0% | $919.3K | 0.5% |
| 150 | −60.0% | $696K | 0.4% | |
| 335 | ±0% | $537.7K | 0.3% | |
KPTIKaryopharm Therapeutics Inc. | 71.8K | New | $87.6K | 0.1% |